Home > Stocks > Highlights
Dow 30 Earnings: Cisco Systems Second Quarter Fiscal 2016

Networking equipment maker and telecom equipment industry bellwether, Cisco Systems has reported better-than-expected January-quarter adjusted earnings per share of $0.57. That figure was $0.03 above our call and 8% more than last year's tally (5% excluding the reinstatement of the federal R&D tax credit). Investors applauded the results and bid depressed CSCO stock sharply higher.

Read more
Dow 30 Earnings: The Walt Disney Company First Quarter Fiscal 2016
Investors' concerns about subscriber trends and rising costs at ESPN overshadowed an incredible performance by Star Wars: The Force Awakens, and Disney shares fell notably to a 52-week low following the media conglomerate’s December-period earnings release. Read more
Dow 30 Earnings: Coca-Cola Fourth Quarter 2015
Beverage giant Coca-Cola delivered an in-line performance in the fourth quarter, with results slightly lower versus the prior-year period. Shares were up modestly following the release. Read more
Republic Services: A Short SWOT Analysis
Shares of environmental services Republic Services (RSG) have been standouts over the past couple of years. The sector is not exactly sexy, to be sure, catering to society’s needs rather than wants. But it’s fundamentally sound, with long-term contracts typically supporting strong free cash flow and good operating leverage. Should individual investors accumulate shares of this best-of-breed waste hauler? Or is the valuation too rich relative to the firm’s growth prospects at present, suggesting that greener pastures can be found elsewhere? In this brief article, we will attempt to address these questions and more by taking a look at Republic’s operations and performing an easy-to-follow SWOT analysis of the company, evaluating its Strengths, Weaknesses, Opportunities, and Threats. Read more
Using The Value Line Report: 3M Faces A Challenging Operating Environment
Many people are familiar with the consumer products offerings of 3M, such as Scotch tape and Post-it notes. But there is much more to the company than its consumer division, which is actually the smallest of five units (reorganized from six previously). Read more
Dow 30 Earnings: Merck Fourth Quarter 2015
Shares of Merck fell modestly after the drugmaker and Dow-30 member reported fourth-quarter results. Earnings were a bit better than expected, but soft 2016 guidance and a top-line miss weighed on the stock. Read more
Dow 30 Earnings: Pfizer Fourth Quarter 2015
Better-than-expected demand for the PREVNAR vaccine franchise and strong growth in the oncology portfolio helps drugmaker and Dow-30 member Pfizer top fourth-quarter adjusted earnings expectations. Read more
Dow 30 Earnings: Exxon Mobil Corp. Fourth Quarter 2015
As expected, oil giant Exxon Mobil reported a substantial drop in fourth-quarter earnings, due to the steep decline in oil prices over the past year, as well as lower natural gas price realizations. Read more
Using The Value Line Report: Can A Tax-Inversion Deal With Allergan Be A Magic Pill for Pfizer
Pharmaceutical giant and Dow member Pfizer (PFE) recently made headlines when it announced in November, 2015 that it is planning to join forces with Ireland-based Botox maker Allergan plc (AGN) in a mega merger worth a jaw-dropping $160 billion. So what does this mean for the individual investor looking to include the blue chip in a portfolio? For anyone seeking to gain insight here, the Value Line report is certainly a good place to start. Read more
Dow 30 Earnings: Chevron Corp. Fourth Quarter 2015
Oil giant Chevron has reported its first quarterly bottom-line loss since the third quarter of 2002. The company reported fourth-quarter sales of $28 billion, 33% lower than the year-earlier tally of $42 billion. The bottom-line deficit was $0.31 a share, compared with last year's profit of $1.85. The stock fell slightly, in response. Read more
[First] [Previous] [Next] [last]
Free stock reports
The Value Line 600
Value Line is regarded as the best independent research available. More than just recommendations, Value Line provides the rationale behind its picks for greater understanding.
- Don D., California